FDA Establishes Over-The-Counter Classification for Infant Pulse Oximeters

The U.S. Food and Drug Administration has officially classified infant pulse rate and oxygen saturation monitors for over-the-counter use. This regulatory action, set for publication today, provides clear guidelines for these medical devices, allowing consumers to purchase them without a prescription. This move aims to enhance accessibility for parents monitoring their infants' vital signs.